pillbase.ru

Zokinvy

Active substance: lonafarnib

CAPSULE · LONAFARNIB 50 mg/1

United StatesActive

Marketing holder: Sentynl Therapeutics, Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 1
  • Zokinvy
    Lonafarnib
    EMEA/H/C/005271
    Integral Pharma Solutions EU Limited
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-59ed-7231-9367-97e81272e43d,01a12093-66bb-73a7-a740-ad70ae6d5d8c;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
42358-450
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 42358-450 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 42358-450 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 42358-450 · Verified 2026-10-09 · open in source